Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation_2026年_学术论文_科研成果_最新资讯_爱尔眼科研究所

首页 > 最新资讯 > 科研成果 > 学术论文 > 2026年 >

Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation

发布日期： 2026-04-01

Yuan Liang , Xihao Sun , Yuqin Liang , Hang Chen , Chunwen Duan , Yuexi Chen , Wenwei Li , Jianing Gu , Zekai Cui , Chengcheng Ding , Jiansu Chen

Establishment of non-integrate induced pluripotent stem cell line CSUASOi013-A, from peripheral blood-derived cells of a PRPF31-related dominant retinitis pigmentosa patient

Tannic Acid Achieves Rapid Scar-Free Corneal Healing by Chelating Excess Copper to Suppress Aberrant LOX-Mediated Fibrosis

相关文章

Establishment of non-integrate induced pluripotent stem cell line CSUASOi013-A, from peripheral blood-derived cells of a PRPF31-related dominant retinitis pigmentosa patient

https://pubmed.ncbi.nlm.nih.gov/42105440/

2026-04-01
Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation

https://pubmed.ncbi.nlm.nih.gov/41864154/

2026-04-01
PRPF8 Mutation-Induced Defects in Human iPSC-Derived RPE Are Rescued by Adenine Base Editing

https://pubmed.ncbi.nlm.nih.gov/41533919/

2026-04-01
一种三维类器官灌流培养器具

本申请涉及细胞和器官培养技术领域，公开了一种三维类器官灌流培养器具，包括：细胞培养室，细胞培养室用于盛放培养基；多个换液槽，设于细胞培养室，用于更换细胞培养室中...

2024-09-04
化合物LM22B-10在制备角膜上皮及神经损伤治疗药物中的应用

本发明涉及生物医药领域，特别涉及化合物LM22B‑10在制备修复角膜上皮及神经创伤的药物中的应用。

2024-09-04
血视网膜外屏障模型及其构建方法，构建该模型采用的培养基组合

本发明涉及生物医药领域，特别涉及血视网膜外屏障模型及其构建方法，构建该模型采用的培养基组合。

2024-09-04
一种培养基、其制备的角膜基质片和制备方法

本发明涉涉及医用生物材料技术领域，特别涉及一种培养基、其制备的角膜基质片和制备方法。

2024-09-04